Skip to main content

Global Digestible Sensors Market Survey and Latest Developments Report 2019, Forecast 2023

 Global Digestible Sensors Market

Digestible Sensors are developed with edible materials and consist of a wearable patch. These sensors are activated upon ingestion and transfer medical information about the patients’ health to the respective medical professionals. The transmitted information or medical data helps the physicians to customize the care given to the patient as well as the to other individuals facing similar health conditions or ailments.

Tiny ingestible sensors use Bluetooth to establish communication with an adhesive pad on the patient's chests. The real-time information is then shared on associated Smartphone app that passes the readings to doctors, family members, and caretakers. The evolving technology is improving overall therapeutic effectiveness, solving problems that have overwhelmed the healthcare industry for decades.

Industry/Innovation/ Related News:

October 10, 2018 – Children’s Health (US), a pediatric health system announced the update on the development of ingestible sensors to tackle adherence issues in pediatric heart transplant patients. The development of the program is proceeding within collaboration with Proteus. This system is made up of the sensor-infused pill and a wearable patch worn by the patient.

When the pill is broken down in the digestive system, it gets activated to transmit a signal to the receiver on the patch worn by the patient. This patch can further transmit information to physicians, patients, and caregivers through a digital platform.

Avail a Free Sample@ https://www.marketresearchfuture.com/sample_request/872

Owing to its tremendous ability and efficacy, digestible sensors are increasingly gaining popularity and consecutively its market is garnering huge traction on the global platform.

Acknowledging the traction, this market is vibrating with currently; Market Research Future (MRFR) in its recently published study report asserts that the global digestible sensors market will grow exponentially by 2027, posting approximately 18.6% CAGR throughout the forecast period of (2016–2027).

Factors that are predominantly driving the digestible sensors market include raising awareness about digestible sensors among the patients and doctors alike. Additionally, the presence of a large number of geriatric populations that needs timely medication but tend to forget at times is forecasted to fuel the market growth.

Patients with mental disorders and Schizophrenia who are incapable of keeping a log of their medications or sometimes even deny medications completely are largely getting benefitted by the digestible sensors. In such cases, Digestible Sensors are reliably helping their caregivers & family members to keep a tab on patients’ medications. Therefore, the reliable assistance it provides fosters the market growth.

Conversely, the lack of awareness towards befits of digestible sensors coupled with the skepticism of physicians are posing challenges to the market growth. Besides, the complexity of production and the high manufacturing cost along with unclear regulatory policies are expected to impede the market growth of digestible sensors during the forecast period.

Nevertheless, technological advancements coupled with growing number of pharma companies that can manufacture digestible sensors on a high production rate are expected to bring the production cost down, which is expected to support the growth of the digestible sensors market during the review period.

Global Digestible Sensors Market – Segmentation

The MRFR analysis is segmented into five key dynamics for the convenience of understanding;

By Product: Strip Sensor, Ingestible Sensor, Invasive Sensors, and Ingestible Sensors, among others

By Application: Diagnostics, Patient Monitoring, and Therapeutics among others.

By Technology: Image, Temperature, Pressure, Biosensors, and Accelerometer among others.

By End-user: Consumer, Pharmaceutical Companies, Healthcare Providers, Sports and Fitness Institutes among others.

By Regions:  North America, Europe, APAC, and the Rest-of-the-World.

Global Digestible Sensors Market – Competitive Analysis

The Global Market of digestible sensors appears to be moderately competitive and consolidated with the limited number of key players operating in the market with the presence of several well-established and small players. Well-established players incorporate acquisition, partnership, collaboration, expansion, and technology launch in order to gain a competitive advantage in this market. Top players invest heavily in R&D and clinical trials to develop effective digestible sensors.

Access Report Details @  https://www.marketresearchfuture.com/reports/digestible-sensors-market-872

Key Players:

The Global Digestible Sensors Market is driven by some of the prominent players including Freescale Semiconductor, Inc., Proteus Digital Health, Philips Healthcare, Analog Devices, Inc., STMicroelectronics, GE Healthcare, Measurement Specialties, Honeywell International, Medtronic Plc, Smiths Medical, and Sensirion AG among others.

TOC:

  1.  Report Prologue    

    2.    Market Introduction   


          2.1    Definition    

          2.2    Scope of the Study    

                2.2.1    Research Objective    

                2.2.2    Assumptions    

                2.2.3    Limitations    

    3.    Research Methodology

          3.1    Introduction

          3.2    Primary Research    

          3.3    Secondary research

          3.4    Market Size Estimation

    TOC…Continued

Ask Questions to Expertise @ https://www.marketresearchfuture.com/enquiry/872

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Comments

Popular posts from this blog

Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Growth Drivers, Restraints and Opportunities, Forecast To 2025

Global Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size Research Report: Information by Treatment (Drug Class (Mitogen-Activated Protein Kinases (MAPK) Inhibitors, Tyrosine Kinase Inhibitors, Autotaxin Inhibitors, Others), Oxygen Therapy, Lung Transplant, Others) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2025 Global  Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Size  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. Some of the key players operating for the global market analysis are  Boehringer Ingelheim GMBH, Biogen, Novartis AG, Medicinova, Inc., Bristol-Myers Squibb Company, Galapagos NV, F. Hoffmann-La R...

Krabbe Disease Treatment Market Set to Surge Significantly with New Innovations, Application, Recent Technology

  Krabbe Disease Treatment Market Overview Krabbe disease is an incurable medical condition where the protective coating of nerve cells around the brain are destroyed which causing nerve damage. The global Krabbe disease treatment market can reach a significant valuation, exhibiting a steady CAGR over the forecast period of 2016 to 2022, as per a research report published by Market Research Future (MRFR). The market has been growing continuously on account of increasing incidence of Krabbe disease across the globe. Classification of Krabbe disease under orphan disease has propelled the growth of the market. Pharmaceutical companies receive incentives to develop medicine for rare disease along with reduced fees in protocol assistance and protection from competition after the medicine is marketed. Increased government funding for drug development and easy approvals, tax credits on clinical research, reduction in the amount of registration fees also aid the growth of the market. These...

Peptic Ulcer Drugs Market Rapid Development By Manufactures Business Growth Future

  Peptic Ulcer Drugs Market Scenario: Peptic ulcer drugs are used to treat erosion of the gastrointestinal lining due to a variety of factors. Peptic ulcer is the result of an imbalance between aggressive and defensive fluids in the stomach. Peptic ulcer includes gastric, esophageal and duodenal ulcer. The global peptic ulcer drugs market was valued at approximately $29 billion in 2015, and is expected to reach $36.27 billion by 2022. Thus, the market is expected to show an average growth at a CAGR of 3.8 % from 2016 to 2022. The major driving factors for petic ulcers drug market are stress, drug induced ulcers, growing rate of infection by H.Pyrroli, changes in food, rise in cancer, tobacco and alcohol use. Constraining factors of this market are patent expiry, comparatively good treatment regimen of proton pump inhibitors, resistance of H.Pyrolli, extreme market fragmentation into many companies and great penetration of generics. Avail a Free Sample@  https://www.market...